Cargando…
Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer
Introduction: Most advanced colorectal cancers are aggressive, and there is a lack of effective methods for selecting appropriate anticancer regimens. Patient-derived organoids (PDOs) have emerged as preclinical platforms for modeling clinical responses to cancer therapy. Methods: In this study, we...
Autores principales: | He, Xingfeng, Jiang, Yan, Zhang, Long, Li, Yaqi, Hu, Xiang, Hua, Guoqiang, Cai, Sanjun, Mo, Shaobo, Peng, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239948/ https://www.ncbi.nlm.nih.gov/pubmed/37284236 http://dx.doi.org/10.3389/fbioe.2023.1190637 |
Ejemplares similares
-
Establishment and identification of organoids from human circulating colorectal cancer cells
por: Zhang, Long, et al.
Publicado: (2020) -
Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
por: Zeng, Xiao, et al.
Publicado: (2023) -
Organoid based personalized medicine: from bench to bedside
por: Li, Yaqi, et al.
Publicado: (2020) -
Review on the Vascularization of Organoids and Organoids-on-a-Chip
por: Zhao, Xingli, et al.
Publicado: (2021) -
Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids
por: Ping, Yanyan, et al.
Publicado: (2020)